URSO, LOREDANA
 Distribuzione geografica
Continente #
NA - Nord America 2.852
AS - Asia 1.455
EU - Europa 996
AF - Africa 358
SA - Sud America 317
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 20
Totale 6.029
Nazione #
US - Stati Uniti d'America 2.635
SG - Singapore 559
CN - Cina 234
BR - Brasile 205
IT - Italia 193
HK - Hong Kong 192
DE - Germania 167
VN - Vietnam 106
FI - Finlandia 98
SE - Svezia 66
PL - Polonia 61
FR - Francia 49
RU - Federazione Russa 36
GB - Regno Unito 32
NL - Olanda 31
IN - India 27
MX - Messico 26
CA - Canada 25
AR - Argentina 24
JP - Giappone 19
KR - Corea 18
RO - Romania 18
EC - Ecuador 17
UA - Ucraina 17
AO - Angola 16
BW - Botswana 16
CZ - Repubblica Ceca 16
ES - Italia 16
PY - Paraguay 16
ID - Indonesia 15
IL - Israele 15
AE - Emirati Arabi Uniti 14
AZ - Azerbaigian 14
BJ - Benin 14
IQ - Iraq 14
YE - Yemen 14
ZA - Sudafrica 14
CW - ???statistics.table.value.countryCode.CW??? 13
KH - Cambogia 13
MD - Moldavia 13
PE - Perù 13
PR - Porto Rico 13
TW - Taiwan 13
BB - Barbados 12
CR - Costa Rica 12
GH - Ghana 12
IE - Irlanda 12
MK - Macedonia 12
MW - Malawi 12
RW - Ruanda 12
UG - Uganda 12
BS - Bahamas 11
CG - Congo 11
CY - Cipro 11
DO - Repubblica Dominicana 11
GR - Grecia 11
ME - Montenegro 11
MR - Mauritania 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
BE - Belgio 10
BZ - Belize 10
CH - Svizzera 10
CI - Costa d'Avorio 10
ET - Etiopia 10
GN - Guinea 10
JO - Giordania 10
ML - Mali 10
MY - Malesia 10
PA - Panama 10
SN - Senegal 10
AT - Austria 9
CM - Camerun 9
CO - Colombia 9
DZ - Algeria 9
EG - Egitto 9
GT - Guatemala 9
HT - Haiti 9
KE - Kenya 9
MA - Marocco 9
MN - Mongolia 9
NP - Nepal 9
SK - Slovacchia (Repubblica Slovacca) 9
TJ - Tagikistan 9
TN - Tunisia 9
TR - Turchia 9
TT - Trinidad e Tobago 9
YT - Mayotte 9
ZM - Zambia 9
AU - Australia 8
BF - Burkina Faso 8
BG - Bulgaria 8
CU - Cuba 8
GF - Guiana Francese 8
GM - Gambi 8
IR - Iran 8
KZ - Kazakistan 8
LA - Repubblica Popolare Democratica del Laos 8
LV - Lettonia 8
PH - Filippine 8
Totale 5.682
Città #
Fairfield 451
Singapore 320
Ashburn 294
Chandler 206
Hong Kong 183
Woodbridge 173
Houston 140
Cambridge 133
Munich 126
Seattle 125
Wilmington 111
San Diego 98
Beijing 71
Helsinki 68
Santa Clara 63
Ann Arbor 59
Boardman 51
Bytom 48
Padova 46
Medford 39
Princeton 39
Ho Chi Minh City 38
Guangzhou 35
Los Angeles 33
New York 27
Des Moines 25
Roxbury 21
São Paulo 21
Hanoi 20
Buffalo 19
Milan 16
Hefei 15
Luanda 15
Cotonou 14
Shanghai 13
Kampala 12
Accra 11
Chicago 11
Kigali 11
Phnom Penh 11
Turku 11
Abidjan 10
Amman 10
Baku 10
Bamako 10
Conakry 10
Dakar 10
Nassau 10
Nouakchott 10
Panama City 10
Seoul 10
Tashkent 10
Bridgetown 9
Brooklyn 9
Dublin 9
Gaborone 9
Guayaquil 9
Lilongwe 9
London 9
Lusaka 9
San Juan 9
Ulan Bator 9
Warsaw 9
Willemstad 9
Belize City 8
Brazzaville 8
Dushanbe 8
Montreal 8
Nanjing 8
Ottawa 8
Ouagadougou 8
Podgorica 8
Rome 8
Skopje 8
Vientiane 8
Villafranca Padovana 8
Abu Dhabi 7
Andorra la Vella 7
Bangkok 7
Belo Horizonte 7
Havana 7
Kingstown 7
Libreville 7
Maitengwe 7
Montevideo 7
Nairobi 7
San José 7
Sanaa 7
Sofia 7
Tel Aviv 7
Tokyo 7
Aden 6
Amsterdam 6
Auckland 6
Guatemala City 6
Johannesburg 6
Kharkiv 6
Kinshasa 6
Lima 6
Mexico City 6
Totale 3.696
Nome #
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 308
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2 weeks letrozole: results of the PerELISA neoadjuvant study 256
211P: Inflammatory cells characterization and localization in malignant pleural mesothelioma (MPM) tissue samples: Correlation with histologic subtype and prognosis 255
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intra-tumor heterogeneity over time 206
Metabolic rewiring and redox alterations in malignant pleural mesothelioma 195
Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists 192
Synergistic Antitumor Activity of Recombinant Human Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Combination with Carboplatin and Pemetrexed in Malignant Pleural Mesothelioma 191
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers 191
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 177
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells 177
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: Correlation with pathological and clinical data 172
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer 169
Liquid biopsy in malignant pleural mesothelioma: State of the art, pitfalls, and perspectives 167
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 167
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial 161
Effects of sulfonylureas on tumor growth: A review of the literature 157
Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancer 155
Synergistic antitumor activity of recombinant human Apo2L/Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma 155
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 149
Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification 148
Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment 145
Mesothelin-targeted agents in mesothelioma 132
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype 129
P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment 125
Effects of cisplatin on matrix metalloproteinase-2 in transformed thyroid cells 118
Functions of epidermal growth factor receptor in cisplatin response of thyroid cells 117
Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment 117
Cisplatin reduces endothelial cell migration via regulation of type 2-matrix metalloproteinase activity 116
Epigenetic Regulation of miR-212 Expression in Lung Cancer 112
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED 112
[Pt(O,O′-acac)(γ-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway 108
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus 106
Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells 105
Differential functions of PKC-delta and PKC-zeta in cisplatin response of normal and transformed thyroid cells 103
Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets 103
Sublethal concentrations of the platinum(II) complex [Pt(O,O′-acac) (γ-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells 96
Anti-apoptotic effects of protein kinase C-δ and c-fos in cisplatin-treated thyroid cells 96
New platinum(II) complexes containing both an O,O′-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells 95
Targeted therapies in mesothelioma 89
Serum osteoprotegerin correlates with age and bone mass in postmenopausal, but not in fertile age women 83
PKC-ε-dependent cytosol-to-membrane translocation of pendrin in rat thyroid PC C13 cells 79
[Pt(O,O′-acac)(γ-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway (British Journal of Pharmacology (2007) 153, (34-49) DOI: 10.1038/sj.bjp.0707646) 68
Totale 6.102
Categoria #
all - tutte 19.715
article - articoli 19.081
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 634
Totale 39.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021472 0 0 0 0 0 41 163 20 75 53 47 73
2021/2022724 40 44 38 15 74 198 35 33 43 68 37 99
2022/2023455 68 57 22 49 60 40 4 26 79 10 31 9
2023/2024289 17 42 41 23 12 42 22 3 10 35 22 20
2024/20251.293 16 111 46 61 131 40 114 159 138 39 186 252
2025/20262.255 195 332 588 748 388 4 0 0 0 0 0 0
Totale 6.102